Nancy Chan
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
-
- Cancer Genomics and Diagnostics
Papers in ⓘ
- Oncology 32
- Cancer Immunotherapy and Biomarkers 9
- Cancer Treatment and Pharmacology 7
- PARP inhibition in cancer therapy 6
- HER2/EGFR in Cancer Research 5
-
- Cancer Genomics and Diagnostics 5
- Cancer, Hypoxia, and Metabolism 5
- Co-authors
- Shridar Ganesan (9 shared papers)Zia A. Khan (3 shared papers)Jyoti Malhotra (12 shared papers)Salma K. Jabbour (3 shared papers)Ann W. Silk (10 shared papers)Eugenia Girda (5 shared papers)Alexandra Kleiman (2 shared papers)Hong Xie (3 shared papers)
- Journals
- Journal of Clinical Oncology (12 papers)Cancer Research (8 papers)Clinical Cancer Research (3 papers)Experimental and Molecular Pathology (2 papers)Drug Delivery and Translational Research (1 paper)
- Partner nations
- United StatesCanadaSpain
In The Last Decade
Nancy Chan
46 papers receiving 858 citations
Hit Papers
Peers
Comparison fields: 5 of 85
- Oncology 373
- Cancer Research 148
- Pulmonary and Respiratory Medicine 241
- Pathology and Forensic Medicine 87
- Surgery 208
Countries citing papers authored by Nancy Chan
This map shows the geographic impact of Nancy Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Chan more than expected).
Fields of papers citing papers by Nancy Chan
This network shows the impact of papers produced by Nancy Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Chan. The network helps show where Nancy Chan may publish in the future.
Co-authors
The 25 scholars most cited alongside Nancy Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers Hit paper breakdown → | 2021 | 196 |
| 2 | 2019 | 187 | |
| 3 | 2017 | 40 | |
| 4 | 2012 | 31 | |
| 5 | 2013 | 27 | |
| 6 | 1999 | 23 | |
| 7 | 2022 | 23 | |
| 8 | Pathological reporting of colorectal cancer specimens: a retrospective survey in an academic Canadian pathology department. | 2008 | 22 |
| 9 | 2012 | 20 | |
| 10 | 2017 | 20 | |
| 11 | 2012 | 19 | |
| 12 | 2018 | 19 | |
| 13 | 1995 | 18 | |
| 14 | 2020 | 18 | |
| 15 | 2013 | 17 | |
| 16 | 2020 | 15 | |
| 17 | 2022 | 14 | |
| 18 | 2016 | 13 | |
| 19 | 2022 | 13 | |
| 20 | 2018 | 13 |
About Nancy Chan
Nancy Chan is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Reproductive Medicine and Biotechnology, having authored 55 papers that have together received 868 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Cancer Treatment and Pharmacology (7 papers), Advanced Breast Cancer Therapies (7 papers), PARP inhibition in cancer therapy (6 papers), HER2/EGFR in Cancer Research (5 papers), Cancer Genomics and Diagnostics (5 papers), Ovarian cancer diagnosis and treatment (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). The work is most often cited by research in Oncology (373 citations), Cancer Research (148 citations), Pulmonary and Respiratory Medicine (241 citations), Pathology and Forensic Medicine (87 citations) and Surgery (208 citations). Nancy Chan has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include Shridar Ganesan, Zia A. Khan, Jyoti Malhotra, Salma K. Jabbour, Ann W. Silk, Eugenia Girda, Alexandra Kleiman, Hong Xie, Roman Groisberg and Josep Tabernero. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Clinical Cancer Research, Experimental and Molecular Pathology and Drug Delivery and Translational Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.